Skip to Content

The Best Datreal Yet: Real Estate Maps, a New Design, Dark Mode. Read the Changelog

Datreal

MAPharm OÜ - Company Valuation

Reference Value. Equity as reported in the selected filing.

Reported Book Equity

0 €
Reference Value
Based on FY
2025
Valuation Date
Business Strength
F
Risks
Negative EquityDistressedLoss-Making

Scope & Evidence

Company
MAPharm OÜ
Registration
EE · 14292621
Covers
Single Company
Filings Used
7 · FY 2025, 2024, 2023, 2022, 2021, 2020, 2019

Key Ratios

Current Ratio
0.67×
Quick Ratio
-
Debt / Equity
-
Equity Ratio
-54.8%
Interest Coverage
-
Gross Margin
-
Net Profit Margin
-6.4%
Return on Equity
-
Return on Assets
-34.7%
Revenue CAGR
24.8%

Liability Maturity

Short-TermLong-Term

3-Year Revenue Scenarios

12m €
9m €
6m €
3m €
0 €
202620272028
OptimisticBaseConservative

Revenue vs Industry Peers

Aaloe Apteegid OÜ
25,205,241 €
osaühing TARTU UUSAPTEEK
21,012,136 €
Marja Apteek OÜ
6,360,605 €
Meluelu OÜ
5,200,441 €
MAPharm OÜ ★
4,174,860 €
Medicik OÜ
3,156,533 €

Revenue, Profit & EBITDA

4.5m €
3m €
1.5m €
0 €
-1.5m €
20212022202320242025
RevenueNet Profit

Versus Industry Median

4.5m €
3m €
1.5m €
0 €
-1.5m €
RevenueNet Profit
This CompanyIndustry Median